News | January 05, 2009

Milan Cancer Center Uses First RapidArc Radiotherapy Treatment

January 6, 2009 - A pancreatic cancer patient at the Humanitas Clinic in Milan, Italy has become the first person in Italy to be treated with Varian’s RapidArc, which is designed to enable doctors to improve outcomes while extending more advanced care to more patients.

"We see three major benefits with RapidArc," added Dr. Marta Scorsetti, lead clinician at Humanitas. "The short treatment time -- under two minutes in this case -- decreases the chances of the patient moving during treatment, which helps to improve precision. RapidArc enables us to spare more healthy tissue from receiving unnecessary dose and we believe this additional precision will enable us to increase the dose, which should contribute to a higher cure rate."

With RapidArc, Varian's Clinac medical linear accelerator can target radiation beams at a tumor while rotating continuously around the patient. Conventional intensity modulated radiotherapy (IMRT) treatments are slower and more difficult for radiotherapy radiographers and patients because they target tumors using a complex sequence of fixed beams from multiple angles.

"The patient reacted very well to the new treatment and he was comfortable throughout the two minutes he was on the treatment table,” said Dr. Scorsetti. “As the overall treatment time was reduced, we will be able to treat more patients and consequently reduce waiting times."

Dr. Scorsetti said pancreatic cancers are not traditional candidates for complex treatments with intensity modulated radiotherapy (IMRT) but the introduction of RapidArc means that such patients as well as prostate and head and neck cancer patients can now receive the most advanced radiotherapy treatments in a short time.

Humanitas, one of the largest hospitals in the Milan urban area, serves up to three million people and treats 150 patients a day in the radiotherapy department. The clinic treats patients using three Varian Clinac accelerators, one of which is equipped with an On-Board Imager device that is necessary for the delivery of RapidArc treatments.

Doctors at Humanitas believe the volumetric arc therapy treatments offered by RapidArc are at the cutting edge of patient care. "While helical tomotherapy has been introduced for specialty treatments by some centers in Italy, we are going a big step further by introducing a volumetric treatment approach that is much faster and far more comfortable for the patient," said Urso Gaetano, a medical physicist at the hospital. "What multi-slice CT scanning did for CT, RapidArc does for radiotherapy."

For more information: www.varian.com

Related Content

New Prostate Cancer Radiotherapy Technique Aims to Preserve Sexual Function
News | Radiation Therapy | June 18, 2018
A multicenter clinical trial being led by UT Southwestern physicians is testing a technique for sparing nerve bundles...
Elekta Unity High-Field MR-Linac Receives CE Mark
News | Image Guided Radiation Therapy (IGRT) | June 18, 2018
Elekta announced that its Elekta Unity magnetic resonance radiation therapy (MR/RT) system has received CE mark,...
Washington University in St. Louis Begins Clinical Treatments With ViewRay MRIdian Linac
News | Image Guided Radiation Therapy (IGRT) | June 14, 2018
June 14, 2018 — The Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in S
Accuray TomoTherapy System Beneficial in Two Total Body Irradiation Studies
News | Radiation Therapy | June 13, 2018
Recently published data from two new studies demonstrate the benefits of Accuray’s TomoTherapy System in the delivery...
IsoRay Funding Brain Cancer Treatment Research With Ochsner Clinic Foundation
News | Brachytherapy Systems | June 12, 2018
IsoRay Inc. announced the initiation of research funding for brain cancer treatment to Ochsner Clinic Foundation, a not...
News | Brachytherapy Systems | June 07, 2018
IsoRay Inc. announced the upcoming release of its Build-Blu delivery system for real-time prostate brachytherapy.
Raysearch RayStation
Feature | Radiation Therapy | June 05, 2018 | By Melinda Taschetta-Millane
Treatment planning systems are at the heart of r...
Lung Decision Precision
News | Lung Cancer | June 04, 2018
For smokers and former smokers, the threat of lung cancer always lurks in the shadows.
Beaumont Researchers Invent New Mode of Proton Treatment for Lung Cancer
News | Proton Therapy | May 31, 2018
Members of Beaumont Health’s proton therapy team presented research on a new treatment for patients with lung cancer at...
More Than 60 Percent of Patients Seeking Proton Therapy Initially Denied Coverage
News | Proton Therapy | May 25, 2018
The Alliance for Proton Therapy Access has released a national report revealing the heavy emotional and financial...
Overlay Init